As a result of the COVID-19 outbreak, the 2020 meeting has been cancelled and will be postponed in Spring 2021. Please check back for additional details for the 2021 meeting dates. You may also email us at email@example.com.
Meeting Chairs: Michel C. Nussenzweig, M.D., Ph.D. and Jeffrey V. Ravetch, M.D., Ph.D, Rockefeller University.
Theme: New Dimensions of Therapeutic Antibodies.
Annual Kunkel Memorial Lecturer: Tadatsugu Taniguchi, PhD, University of Tokyo who will be speaking about advances in the treatment of inflammatory diseases and cancer.
The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world.
In 2020, CIMT invites international participants for high-level scientific exchange, collaboration, and education focused on cancer immunotherapy.
The CIMT program committee is preparing plenary sessions from pre-clinical research to clinical development on the topics of neoantigens, combination therapies, microbiota, immune escape, cellular therapy, improving immunity, tumor microenvironment, regulatory research and immunoguiding. The plenary sessions will be complemented by a poster exhibit and selected poster short talk sessions, as well as industry symposia and industry exhibits.
The short talk sessions will feature more than 40 presentations, selected from all abstract submissions in a double-blind peer review.
This two-day meeting will convene experts in tumor immunology, cancer genetics and computational biology to discuss innovative methods to analyze both the tumor and the host immune system and highlight the links between tumor genotype, immune phenotype and patient response. Key themes under discussion will include tumor evolution, neoantigens, novel therapeutic targets, and mechanisms driving the emergence of resistance to current therapy.
The deadline for abstract submission is Tuesday, March 03, 2020.
Since 2017, ITOX 2020 is the first symposium dedicated to immunotherapy toxicities gathering Clinicians, Scientists and Pharmacists to share experiences, expertise and exploration of toxicities to improve knowledge and management of patients treated by cancer immunotherapies. Symposium located at UICP Congress Space, 16 rue Jean Rey - 75015 Paris.
Oxford Global’s Immuno Series features 2 outstanding programmes consisting of key discussion topics in Immuno-Oncology, Autoimmunity, Immunology and Inflammation, enabling attendees to gain actionable insights into the approaches impacting this field from the leading immunotherapy experts.
Join the 5th Annual Advances in Immuno-Oncology Congress on 21-22 May in London, UK and network with 350+ leaders at the forefront of research into the immune system. Connect with experts from pharma, biotech and academia working on the delivery of innovative immunotherapies.
ICoMI 2020 Congress is a forceful and up-to-date platform where open-minded discussions will promote networking between researchers, clinicians, students and all persons involved in the development of science and medicine. It will be a great opportunity to let new creative and innovative ideas make new collaborations and highlight the latest technology that will help us to reduce the time to find new medication or combinations of treatment especially in the field of chronic diseases.
Antibody Industrial Symposium AIS2020 jointly organized by the scientific society LabEx MAbImprove
and MabDesign, the French association of the Immunotherapy Industrial sector, will be held the 22nd and 23rd of June 2020 in Montpellier. This year edition will focus on a major theme chosen by the Scientific Advisory Board: “Multispecific Abs, Ab-like molecules and adoptive cell therapy for fighting diseases”. It includes keynote lectures, pitch talks around new creative projects, and industrial talks from big pharmaceutical companies.
Moreover, the program will allow opportunities for networking, companies to showcase their new products and technologies as well as dedicated time for business partnering.
Hosted by Arthur L. Irving Family Foundation, this symposium/workshop will focus on advancing the careers of young scientists in cancer immunology. Fifteen accomplished faculty mentors will share their research career experience in cancer immunology with ~40 promising young scientists (post-docs, advanced graduate students and starting faculty). Participants will learn how excellent science can be advanced by formulating questions, designing and executing studies to address these questions, hiring, mentoring, collaborating, leadership, raising funds, and publishing. Sessions will include lectures, small discussion/working groups with faculty mentors on specific topics, and review sessions to integrate lessons learned. Participants will also work on updating their research statement to support their next stage of career development. Applicants will be selected by a committee based on the applicant’s research achievements and plans, and recommendations by their mentors. Applications are due by Feb 15, 2020 and participants will be informed of acceptance in March 2020.
Over the past 8 years, CHI's Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across all modalities and stages in the pipeline. Every year, we assemble an international mix of thought leaders and decision makers from industry and academia to bring you the latest developments in immuno-oncology, while providing access to a comprehensive 5-day program and extensive networking opportunities that CHI's IO Summit provides.
The ESMO Congress is the most influential oncology platform in Europe for clinicians, researchers, patient advocates, journalists and the pharmaceutical industry from all over the world. ESMO Congress 2020 will present the very latest advances in oncology and translate science into better cancer patient care.
The ESMO Congress 2020 programme will be developed by a committee composed of more than 300 international experts under the leadership of Scientific Chair Prof John Haanen, NKI Amsterdam, Netherlands, a leading expert in the field of immunotherapy.
The Cancer Research Institute (CRI), the European Network for Cancer Immunotherapy (ENCI), and the American Association for Cancer Research (AACR) are proud to present the Sixth International Cancer lmmunotherapy Conference.
The 2020 meeting will be held at the New York Hilton Midtown in New York City from September 14-17, 2020. The program will focus on "Translating Science into Survival," and feature talks from more than 50 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy.
This meeting will provide an unparalleled opportunity for teaching, learning, and networking among all stakeholders in the field: scientists, clinicians, regulators, drug developers, and patient advocates.
The 7th Immunotherapy of Cancer Conference (ITOC7) is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges.
ITOC7 is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the Society for Immunotherapy of Cancer (SITC), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.
The Leipzig Immune ONcology (LION) Conference will bring together clinicians, scientists and industry to discuss latest developments and highlights on special issues of immune oncology. The annual meeting is organized by the Fraunhofer Institute for Cell Therapy and Immunology and the University Cancer Center of the University Hospital Leipzig.